Maximilian Diehn, Ph.D.
Affiliations: | 2004 | Stanford University, Palo Alto, CA |
Area:
gene expressionGoogle:
"Maximilian Diehn"Parents
Sign in to add mentor| Patrick O. Brown | grad student | 2004 | Stanford | |
| (Exploring genomic expression programs in normal and malignant cells of the immune and central nervous systems.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gensheimer MF, Kotha NV, Vitzthum LK, et al. (2024) A phase 2 single-arm trial of high-dose precision targeted radiotherapy added to immunotherapy for patients with metastatic non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics |
| Murciano-Goroff YR, Hui AB, Araujo Filho JA, et al. (2024) Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer. Jco Precision Oncology. 8: e2400216 |
| Jun S, Shukla NA, Durm G, et al. (2024) Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
| Azad TD, Nanjo S, Jin MC, et al. (2024) Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis. Npj Precision Oncology. 8: 121 |
| Alig SK, Esfahani MS, Garofalo A, et al. (2023) Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling. Nature |
| Spurr LF, Martinez CA, Kang W, et al. (2022) Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade. Nature Cancer |
| Nair VS, Hui AB, Chabon JJ, et al. (2022) Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer. Cancer Research |
| Esfahani MS, Hamilton EG, Mehrmohamadi M, et al. (2022) Inferring gene expression from cell-free DNA fragmentation profiles. Nature Biotechnology |
| Moding EJ, Nabet BY, Alizadeh AA, et al. (2021) Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease. Cancer Discovery |
| Moding EJ, Liu Y, Nabet BY, et al. (2020) Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer. Nature Cancer. 1: 176-183 |